Abstract
Although non-motor symptoms (NMS) of Parkinson’s disease (PD) are very common also in early stages of the disease, they are still under-recognized. Screening tools for non-motor symptoms, such as non-motor symptoms questionnaire (NMSQuest), help clinicians to recognize NMS and to evaluate if patients could require further assessment or specific treatments. To validate an adapted Italian version of NMSQuest and study its psychometric properties, Italian PD patients self-completed Italian NMSQuest, and then underwent a standard clinical evaluation including motor assessment (by Hoehn and Yahr staging, unified Parkinson’s disease rating scale part III) and non-motor assessment (by Montreal cognitive assessment, Beck depression inventory, neuropsychiatric inventory, Epworth sleepiness scale, scale for outcomes in Parkinson’s disease-Autonomic and movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale part I). Somatic comorbidities were quantified using the modified cumulative illness rating scale (CIRS). Seventy-one subjects were assessed (mean age years 69.8 ± 9.6 SD; 31% women; mean duration of disease 6.3 ± 4.6 years; H&Y median 2). Italian NMSQuest showed adequate satisfactory clinimetrics in terms of data quality, precision, acceptability, internal consistency and reliability. A significant correlation was found between NMSQuest and most of non-motor assessment scales, while no significant correlation appeared with motor severity as well as with age of patients, disease duration, levodopa equivalent daily dose, l-DOPA/dopamine agonists assumption and CIRS total score. The Italian version of the NMSQuest resulted as a reliable instrument for screening NMS in Italian PD patients.
Similar content being viewed by others
References
Chaudhuri KR, Sauerbier A, Rojo JM et al (2015) The burden of non-motor symptoms in Parkinson’s disease using a self-completed non-motor questionnaire: a simple grading system. Parkinsonism Relat Disord 21:287–291. doi:10.1016/j.parkreldis.2014.12.031
Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM et al (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Mov Disord Off J Mov Disord Soc 26:399–406. doi:10.1002/mds.23462
Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464–474. doi:10.1016/S1474-4422(09)70068-7
Chaudhuri KR, Martinez-Martin P, Schapira AHV et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord Off J Mov Disord Soc 21:916–923. doi:10.1002/mds.20844
Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39
Wild D, Grove A, Martin M et al (2005) Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health J Int Soc Pharmacoeconomics Outcomes Res 8:94–104. doi:10.1111/j.1524-4733.2005.04054.x
World Health Organization-Process of translation and adaptation of instruments. http://www.who.int/substance_abuse/research_tools/translation/en/
Martinez-Martin P, Schapira AHV, Stocchi F et al (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord Off J Mov Disord Soc 22:1623–1629. doi:10.1002/mds.21586
Tomlinson CL, Stowe R, Patel S et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord Off J Mov Disord Soc 25:2649–2653. doi:10.1002/mds.23429
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2003) The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord Off J Mov Disord Soc 18:738–750. doi:10.1002/mds.10473
Salvi F, Miller MD, Grilli A et al (2008) A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc 56:1926–1931. doi:10.1111/j.1532-5415.2008.01935.x
Gill DJ, Freshman A, Blender JA, Ravina B (2008) The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson’s disease. Mov Disord Off J Mov Disord Soc 23:1043–1046. doi:10.1002/mds.22017
Levin BE, Llabre MM, Weiner WJ (1988) Parkinson’s disease and depression: psychometric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatry 51:1401–1404
Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545
Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord Off J Mov Disord Soc 19:1306–1312. doi:10.1002/mds.20153
Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord Off J Mov Disord Soc 23:2129–2170. doi:10.1002/mds.22340
Martinez-Martin P, Rodriguez-Blazquez C, Abe K et al (2009) International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 73:1584–1591. doi:10.1212/WNL.0b013e3181c0d416
Bulmer MG (1979) Principles of statistics. Dover, New York
Cova I, Di Battista ME, Vanacore N et al (2016) Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson’s disease. Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2016.10.020
Li H, Zhang M, Chen M et al (2015) Validation of the nonmotor symptoms questionnaire for Parkinson’s disease: results from a Chinese pilot study. Int J Neurosci 125:929–935. doi:10.3109/00207454.2014.986573
Daulatzai MA (2014) Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia. Neurochem Res 39:624–644. doi:10.1007/s11064-014-1266-6
Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord Off J Mov Disord Soc 24:1641–1649. doi:10.1002/mds.22643
Hinnell C, Hurt CS, Landau S et al (2012) Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson’s disease? Mov Disord Off J Mov Disord Soc 27:236–241. doi:10.1002/mds.23961
Acknowledgements
We are grateful to Prof. Chaudhuri for his permission to use and translate the NMSQuest.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cova, I., Di Battista, M.E., Vanacore, N. et al. Adaptation and psychometric properties of the Italian version of the Non-Motor Symptoms Questionnaire for Parkinson’s disease. Neurol Sci 38, 673–678 (2017). https://doi.org/10.1007/s10072-017-2830-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-2830-z